SB
This biotechnology company specializes in extracting active pharmaceutical ingredients (APIs) from cannabis plants using a reliable plant-biotech process that achieves high yields at low costs. By providing these therapeutic compounds, the company enables researchers to develop new drugs that can enhance healthcare outcomes for patients.
Updated 3 months ago
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This biotechnology company specializes in extracting active pharmaceutical ingredients (APIs) from cannabis plants using a reliable plant-biotech process that achieves high yields at low costs. By providing these therapeutic compounds, the company enables researchers to develop new drugs that can enhance healthcare outcomes for patients.